This study is testing whether a daily oral medication called Tinlarebant can slow the progression of geographic atrophy (GA), an advanced form of age-related macular degeneration that causes permanent vision loss. About 429 participants with GA will be randomly assigned to take e…
Phase: PHASE3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC